PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,284 | +41.9% | 888 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $7,247 | +44.9% | 886 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -16.7% | 886 | +30.9% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | -66.7% | 677 | -21.6% | 0.00% | -66.7% |
| Q4 2021 | $18,000 | +5.9% | 864 | +28.4% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +21.4% | 673 | +63.3% | 0.00% | +50.0% |
| Q2 2021 | $14,000 | +16.7% | 412 | +10.5% | 0.00% | -60.0% |
| Q1 2021 | $12,000 | +1100.0% | 373 | +646.0% | 0.01% | – |
| Q4 2020 | $1,000 | – | 50 | +51.5% | 0.00% | – |
| Q3 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 33 | +312.5% | 0.00% | – |
| Q4 2019 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |